New Medicare Pathway Proposed for Breakthrough Medical Devices by CMS and FDA
Federal regulators are set to unveil a new Medicare coverage pathway aimed at accelerating access to FDA-designated breakthrough medical devices, enhancing treatment options for patients.
Editorial Staff
1 min read
Updated 16 days ago
On April 23, 2026, the Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA) announced a collaboration to expedite reimbursement processes for breakthrough medical devices.
This new pathway is designed specifically for devices that have received breakthrough designation from the FDA, which could significantly improve patient access to innovative treatments.
The initiative reflects ongoing efforts by federal regulators to streamline healthcare services and support advancements in medical technology.